THC Farmaceuticals, Inc (CBDG) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
7170 E. MCDONALD DRIVE SCOTTSDALE, AZ 85253 |
| State of Incorp. | UT |
| Fiscal Year End | September 30 |
| Industry (SIC) | 6199 - Finance Services (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2015 MRQ | 9/30/2014 | 9/30/2013 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 1 | 1 | |||
| Cash and cash equivalent | 1 | 1 | |||
| Receivables | 2 | 2 | |||
| Total current assets: | 2 | 2 | |||
| Noncurrent Assets | |||||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 12 | 13 | |||
| Intangible asset, including goodwill, after accumulated amortization | 34 | 34 | |||
| Intangible asset, excluding goodwill, after accumulated amortization | 34 | 34 | |||
| Total noncurrent assets: | 46 | 46 | |||
| TOTAL ASSETS: | 48 | 49 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5 | ||||
| Accounts payable | 5 | ||||
| Due to related parties | 1 | ||||
| Other undisclosed current liabilities | 3 | ||||
| Total current liabilities: | 6 | 3 | |||
| Noncurrent Liabilities | |||||
| Liabilities, other than long-term debt | 78 | ||||
| Due to related parties | 78 | ||||
| Other undisclosed noncurrent liabilities | 12 | 63 | |||
| Total noncurrent liabilities: | 90 | 63 | |||
| Total liabilities: | 96 | 66 | |||
| Equity | |||||
| Equity, attributable to parent | (48) | (17) | |||
| Common stock | 9 | 9 | |||
| Additional paid in capital | 84 | 84 | |||
| Accumulated deficit | (141) | (110) | |||
| Total equity: | (48) | (17) | |||
| TOTAL LIABILITIES AND EQUITY: | 48 | 49 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2015 TTM | 9/30/2014 | 9/30/2013 | ||
|---|---|---|---|---|
| Revenues (Financial Services Revenue) | 19 | 22 | ||
| Gross profit: | 19 | 22 | ||
| Operating expenses | (43) | (41) | ||
| Operating loss: | (24) | (20) | ||
| Interest and debt expense | (0) | (4) | ||
| Loss from continuing operations before income taxes: | (24) | (24) | ||
| Income tax benefit | 6 | |||
| Loss from continuing operations: | (18) | (24) | ||
| Loss before gain (loss) on sale of properties: | (18) | (24) | ||
| Net loss: | (18) | (24) | ||
| Other undisclosed net loss attributable to parent | (13) | |||
| Net loss available to common stockholders, diluted: | (31) | (24) | ||
Comprehensive Income ($ in thousands)
| 6/30/2015 TTM | 9/30/2014 | 9/30/2013 | ||
|---|---|---|---|---|
| Net loss: | (18) | (24) | ||
| Comprehensive loss, net of tax, attributable to parent: | (18) | (24) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.